Ahmadu Kanduwa’s home is just two kilometers away from the local clinic in Nigeria’s northern Sumaila district — two kilometers from the vaccine that could have prevented his son, Isa, from contradicting polio more than a year ago. It’s something Kanduwa thinks about often.